Bent Frandsen
Directeur Général chez EXPRES2ION BIOTECH HOLDING AB
Postes actifs de Bent Frandsen
Sociétés | Poste | Début | Fin |
---|---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Directeur Général | 20/12/2019 | - |
Investor Relations Contact | 01/01/2016 | - | |
Corporate Officer/Principal | 01/01/2016 | 20/12/2019 | |
Adaptvac ApS | Directeur/Membre du Conseil | 01/01/2017 | - |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Directeur Général | - | - |
Historique de carrière de Bent Frandsen
Anciens postes connus de Bent Frandsen
Sociétés | Poste | Début | Fin |
---|---|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Formation de Bent Frandsen
Copenhagen Business School | Graduate Degree |
Statistiques
Internationale
Danemark | 6 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Investor Relations Contact | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Entreprise privées | 3 |
---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Adaptvac ApS | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
- Bourse
- Insiders
- Bent Frandsen
- Expérience